Latest News

TechTarget, Inc. (TTGT) Q2 2026 Earnings Call Transcript
TechTarget, Inc. (TTGT) Q2 2026 Earnings Call Transcript

Genel rejects £202 million cash approach from DNO
Genel Energy PLC (LSE:GENL, FRA:4VL, OTC:GEGYY) has rejected a £202 million cash approach from DNO, its Norwegian rival in the Kurdistan region of Iraq. DNO has taken the proposal public after being r

JD Sports appoints Peter Agnefjäll as chair from September
JD Sports Fashion PLC (LSE:JD., OTC:JDSPY) has appointed Peter Agnefjäll as chair of the board with effect from 1 September 2026.

JFrog Ltd. (FROG) Q2 2026 Earnings Call Transcript
JFrog Ltd. (FROG) Q2 2026 Earnings Call Transcript

Pacific Basin Shipping Limited (PCFBY) Q2 2026 Earnings Call Transcript
Pacific Basin Shipping Limited (PCFBY) Q2 2026 Earnings Call Transcript

Kingsway Corporation (KWY) Q2 2026 Earnings Call Transcript
Kingsway Corporation (KWY) Q2 2026 Earnings Call Transcript

Navient Corporation (NAVI) Q2 2026 Earnings Call Transcript
Navient Corporation (NAVI) Q2 2026 Earnings Call Transcript

Organogenesis Holdings Inc. (ORGO) Q2 2026 Earnings Call Transcript
Organogenesis Holdings Inc. (ORGO) Q2 2026 Earnings Call Transcript

Insight Enterprises Q2 Earnings Call Highlights
Insight Enterprises NASDAQ: NSIT reported second-quarter results that exceeded its expectations, with broad-based growth in hardware, cloud and services helping drive operating leverage. The company r

NetScout Systems Q1 Earnings Call Highlights
NetScout Systems NASDAQ: NTCT reported first-quarter fiscal 2027 revenue growth of 13%, citing demand for its service assurance offerings, government-related orders and contributions from its recently

NETGEAR Q2 Earnings Call Highlights
NETGEAR NASDAQ: NTGR reported second-quarter 2026 revenue of $168.6 million, down 1.2% from a year earlier but up 6.1% sequentially, as growth in its enterprise segment offset continued pressure in co

Intellia Therapeutics Q2 Earnings Call Highlights
Intellia Therapeutics NASDAQ: NTLA said it advanced its lead gene-editing programs during the second quarter, highlighting positive Phase III results for lonvo-z in hereditary angioedema and the resum

Natera Q2 Earnings Call Highlights
Natera NASDAQ: NTRA reported second-quarter 2026 revenue of approximately $753 million, up about 38% from a year earlier, as record testing volumes and higher average selling prices supported growth a

Novavax Q2 Earnings Call Highlights
Novavax NASDAQ: NVAX reported second-quarter 2026 revenue of $57 million and a net loss of $53 million, while highlighting progress in its Sanofi partnership, expanding use of its Matrix-M adjuvant pl

Nova Q2 Earnings Call Highlights
Nova NASDAQ: NVMI reported record second-quarter revenue of $255 million, up 8% sequentially and 16% from a year earlier, as demand increased across its semiconductor process-control portfolio. The co

OmniAb Q2 Earnings Call Highlights
OmniAb NASDAQ: OABI reported higher second-quarter revenue and a narrower net loss as milestone payments from partner programs increased, while the company raised its full-year 2026 revenue and year-e

HTZ Investors Have Opportunity to Lead Hertz Global Holdings, Inc. Securities Fraud Lawsuit
NEW YORK, Aug. 7, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hertz Global Holdings, Inc. (NASDAQ: HTZ) between May 7, 2026 and June 2

EverCommerce Inc. (EVCM) Q2 2026 Earnings Call Transcript
EverCommerce Inc. (EVCM) Q2 2026 Earnings Call Transcript

Lineage Cell Therapeutics, Inc. (LCTX) Q2 2026 Earnings Call Transcript
Lineage Cell Therapeutics, Inc. (LCTX) Q2 2026 Earnings Call Transcript

Reckitt Benckiser: Core Brands Remain Undervalued Despite Mead Johnson Litigation Risk
I rate Reckitt Benckiser a buy with a 12–24 month horizon and medium confidence, citing a 21% discount to peer multiples despite litigation overhang. Core Reckitt delivers high-margin, volume-led grow